Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
July 30, 2018 Cover
Volume 96, Issue 31
Chemical profits continue to rise as the global economy booms
Cover image:The words "Global Top 50" Floating in front of a chemical piping system
Credit: Will Ludwig/C&EN/Shutterstock
Quote of the Week
C&EN’s Global Top 50 chemical companies
Chemical profits continue to rise as the global economy booms
Meet the exosome, the rising star in drug delivery
Companies are hoping to use the vesicles to package small-molecule, protein, and RNA drugs or even use them as therapies themselves
The unexpected source of that luxury feel in car interiors
Japanese firms are the major players in synthetic suede used in high-end vehicle seats
-
What’s ice cream, and why do we scream for it?
Innovations in food science continually improve on this classic sweet treat
-
Your guide to the ACS national meeting in Boston
-
ADVERTISEMENT
Science Concentrates
Paper describing piperlongumine anticancer activity retracted
Some coauthors dissent from withdrawal of report, for which key findings have been independently confirmed
Business & Policy Concentrates
- GSK, 23andMe to apply personal genetics to drug discovery
- Hope and skepticism abound around Biogen and Eisai Alzheimer’s trial
- Chemical toxicity assessments by U.S. EPA to be reshaped, if bill passes
- Women chemists still face discrimination in academia
- Shintech will spend $1.5 billion to cement role as largest vinyl producer
